Product Program year 2022 Source: CMS Open Payments

Lutonix Drug Coated Balloon

Device BD Interventional Peripheral Intervention

PDI 00801741199462

Open in the dashboard

General payments

$40,853

848 payments

Research payments

$373,136

65 payments

Through program year 2022, $40,853 in general payments and $373,136 in research payments were reported against Lutonix Drug Coated Balloon (BD Interventional Peripheral Intervention).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

3 rows
Year Kind Amount Payments
2022 General $40,853 848
2022 Research $258,157 24
2021 Research $114,979 41

Breakdown

Who paid General payments · program year 2022
  1. Bard Peripheral Vascular, Inc. $40,183 838 payments
  2. Becton, Dickinson and Company $670 10 payments
Top recipients General payments · program year 2022
  1. Daniel Han Vascular Surgery · New York, NY $797 2% · 2 payments
  2. Peter Faries Vascular Surgery · New York, NY $595 1% · 4 payments
  3. Luis Leon Vascular Surgery · Phoenix, AZ $442 1% · 5 payments
  4. Erik Stilp Internal Medicine · Milwaukee, WI $404 <1% · 3 payments
  5. John Danks Vascular Surgery · Paramus, NJ $392 <1% · 6 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2022.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2022
  1. Vascular Surgery Surgery $14,954 37% · 164 practitioners
  2. Interventional Cardiology Internal Medicine $4,210 10% · 63 practitioners
  3. Vascular & Interventional Radiology Radiology $3,332 8% · 55 practitioners
  4. Cardiovascular Disease Internal Medicine $3,141 8% · 44 practitioners
  5. Diagnostic Radiology Radiology $2,122 5% · 47 practitioners

The top 5 of 49 specialties; each share is of general payments naming this product to practitioners with a specialty in 2022. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2022
  1. Texas $5,986 15% · 86 recipients
  2. New York $4,714 12% · 35 recipients
  3. Arizona $4,008 10% · 39 recipients
  4. California $2,954 7% · 46 recipients
  5. New Jersey $2,650 6% · 24 recipients

The top 5 of 45 states; each share is of general payments naming this product in 2022 where a state was reported.

The top 25 states, free in the app

848 general · 65 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2022

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record